7 results
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
titrate up to effects ... only few side effects ... Renal #Dosing #Pharmacology ... #Management #Diabetes ... #DM2 #Endocrinology
Euglycemic Diabetic Ketoacidosis (EuDKA)
SGLT2 Inhibitors
Increasing Indications
Significant Adverse Drug Effects
Definition of EuDKA
 • Metabolic acidosis with pH
Euglycemic Diabetic ... (EuDKA) SGLT2 Inhibitors ... Significant Adverse Drug Effects ... Ketoacidosis #EuDKA #diagnosis ... #management #endocrinology
Diuretics and Agents Regulating Renal Excretion

Carbonic Anhydrase Inhibitors (Acetazolamide, Dichlorphenamide)
 • Glaucoma
 • Epilepsy
 • Altitude
disequilibrium syndrome • Diagnosis ... irrigation • Management ... • Nephrogenic diabetes ... stones caused by Ca2 ... Diuresis #Nephrology #Pharmacology
Ketosis Disorders
Ketone bodies are a normal metabolic energy source. Excessive unregulated production of ketones, often accompanied
alcoholics, often can ... • Diabetic ketoacidosis ... seen with SGLT inhibitors ... #differential #diagnosis ... #management #endocrinology
Portopulmonary Hypertension
Presence of pulmonary arterial hypertension in a patient with portal hypertension
No other obvious causes (chronic
m/s • Other signs ... Pulmonary artery diameter ... Phosphodiesterase-5 inhibitors ... the vasodilatory effects ... #management #hepatology
Neurological Side Effects of Antipsychotic Drugs
Acute dystonia - Spasm of muscles of tongue, face, neck, back
Neurological Side Effects ... Antiparkinsonian agents are diagnostic ... discontinuation VMAT2 inhibitors ... #SideEffects #pharmacology ... #management
Management of Anthracyclines and HER2 Antagonist Cardiotoxicity
Anthracyclines cause cardiomyopathy:
 ✖ Reduction in left ventricular ejection fraction
Management of Anthracyclines ... fraction (LVEF) can ... hypertension, diabetes ... monitoring to detect ... cardiology #oncology #pharmacology